Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and atrial natriuretic factor

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with atrial natriuretic factor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujisawa, N; Ikenaka, Y; Ishizuka, M; Nakayama, SM1
Cha, SA; Gao, S; Kim, SH; Park, BM1

Other Studies

2 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and atrial natriuretic factor

ArticleYear
TCDD‑induced chick cardiotoxicity is abolished by a selective cyclooxygenase‑2 (COX‑2) inhibitor NS398.
    Archives of toxicology, 2014, Volume: 88, Issue:9

    Topics: Animals; Animals, Inbred Strains; Antidotes; Aryl Hydrocarbon Hydroxylases; Atrial Natriuretic Factor; Avian Proteins; Chick Embryo; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Embryonic Development; Environmental Pollutants; Gene Expression Regulation, Enzymologic; Heart; Heart Defects, Congenital; Myocardium; Nitrobenzenes; Organ Size; Polychlorinated Dibenzodioxins; Random Allocation; Sulfonamides; Teratogens

2014
Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release.
    Peptides, 2015, Volume: 69

    Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Hypertension, Renovascular; Natriuretic Peptide, Brain; Nitrobenzenes; Rats; Sulfonamides

2015